A detailed history of Profund Advisors LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Profund Advisors LLC holds 11,904 shares of WVE stock, worth $169,870. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,904
Previous 10,625 12.04%
Holding current value
$169,870
Previous $53,000 83.02%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.12 - $9.01 $6,548 - $11,523
1,279 Added 12.04%
11,904 $97,000
Q2 2024

Aug 13, 2024

BUY
$4.38 - $6.48 $46,537 - $68,850
10,625 New
10,625 $53,000
Q4 2018

Feb 14, 2019

SELL
$37.1 - $50.11 $181,641 - $245,338
-4,896 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$36.35 - $55.2 $177,969 - $270,259
4,896 New
4,896 $245,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.24B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.